HPV type-specific detection may promote cervical screening program and vaccination developmentworldwide. We conduct a study comparing HPV Hybrid capture II (HC II) Test and Hybribio GenoArray test,a newly developed HPV type-specific assay, in patients with cervical epithelial neoplasm. Results showed agood concordance in cervical HPV detection between two tests (kappa value 0.80, p<0.05, McNemar test). Ourstudy may promote utilization of type-specific HPV detection that is helpful for cervical cancer screening andvaccination.
(2014). Concordance in Cervical HPV Detection between Hybrid Capture 2 and HPV GenoArray Tests. Asian Pacific Journal of Cancer Prevention, 15(11), 4465-4466.
MLA
. "Concordance in Cervical HPV Detection between Hybrid Capture 2 and HPV GenoArray Tests". Asian Pacific Journal of Cancer Prevention, 15, 11, 2014, 4465-4466.
HARVARD
(2014). 'Concordance in Cervical HPV Detection between Hybrid Capture 2 and HPV GenoArray Tests', Asian Pacific Journal of Cancer Prevention, 15(11), pp. 4465-4466.
VANCOUVER
Concordance in Cervical HPV Detection between Hybrid Capture 2 and HPV GenoArray Tests. Asian Pacific Journal of Cancer Prevention, 2014; 15(11): 4465-4466.
)